Envoy Medical Secures Patent for Safe Recharge Tech in Fully Implanted Hearing Devices
Envoy Medical was awarded a new patent for its recharge system that maintains safe temperatures when recharging implantable batteries.
Envoy Medical was awarded a new patent for its recharge system that maintains safe temperatures when recharging implantable batteries.
Oticon's new active transcutaneous bone conduction hearing system offers an alternative to existing percutaneous systems.
New deep neural network noise reduction technology found in Phonak Audéo Sphere Infinio improves listening effort for hearing aid users.
University Hospitals Cleveland Medical Center and UH Rainbow Babies and Children’s Hospital are participating in a Cochlear Americas’-sponsored clinical trial for an implantable hearing device in children 5 to 11 years of age who have been born with hearing loss that may be caused by craniofacial abnormalities.
Cochlear Limited will support the transition of Oticon Medical's 20,000 cochlear implant customers to the company's technology.
Envoy Medical Corporation, a hearing health company focused on providing innovative technologies across the hearing loss spectrum, announced an independent study that was published online in 'The Journal of Laryngology & Otology.' The study found that the fully implanted Esteem osseointegrated active middle ear implant (AMEI) showed “statistically significant improvements in post-operative hearing results,” according to Envoy.